US Army Institute of Surgical Research, San Antonio, TX; Joint Trauma System, San Antonio, TX; Uniformed Services University of the Health Sciences, Bethesda, MD.
The Geneva Foundation, San Antonio, TX.
Surgery. 2022 Feb;171(2):518-525. doi: 10.1016/j.surg.2021.05.051. Epub 2021 Jul 10.
Death from uncontrolled hemorrhage occurs rapidly, particularly among combat casualties. The US military has used warm fresh whole blood during combat operations owing to clinical and operational exigencies, but published outcomes data are limited. We compared early mortality between casualties who received warm fresh whole blood versus no warm fresh whole blood.
Casualties injured in Afghanistan from 2008 to 2014 who received ≥2 red blood cell containing units were reviewed using records from the Joint Trauma System Role 2 Database. The primary outcome was 6-hour mortality. Patients who received red blood cells solely from component therapy were categorized as the non-warm fresh whole blood group. Non- warm fresh whole blood patients were frequency-matched to warm fresh whole blood patients on identical strata by injury type, patient affiliation, tourniquet use, prehospital transfusion, and average hourly unit red blood cell transfusion rates, creating clinically unique strata. Multilevel mixed effects logistic regression adjusted for the matching, immortal time bias, and other covariates.
The 1,105 study patients (221 warm fresh whole blood, 884 non-warm fresh whole blood) were classified into 29 unique clinical strata. The adjusted odds ratio of 6-hour mortality was 0.27 (95% confidence interval 0.13-0.58) for the warm fresh whole blood versus non-warm fresh whole blood group. The reduction in mortality increased in magnitude (odds ratio = 0.15, P = .024) among the subgroup of 422 patients with complete data allowing adjustment for seven additional covariates. There was a dose-dependent effect of warm fresh whole blood, with patients receiving higher warm fresh whole blood dose (>33% of red blood cell-containing units) having significantly lower mortality versus the non-warm fresh whole blood group.
Warm fresh whole blood resuscitation was associated with a significant reduction in 6-hour mortality versus non-warm fresh whole blood in combat casualties, with a dose-dependent effect. These findings support warm fresh whole blood use for hemorrhage control as well as expanded study in military and civilian trauma settings.
无法控制的出血导致的死亡发生迅速,尤其是在战场上的伤员中。由于临床和作战的紧急需要,美国军方在作战行动中使用了温热的新鲜全血,但发表的结果数据有限。我们比较了接受温热新鲜全血和未接受温热新鲜全血的伤员之间的早期死亡率。
使用来自联合创伤系统 2 级数据库的记录,对 2008 年至 2014 年在阿富汗受伤并接受了≥2 个含红细胞单位的伤员进行了回顾性研究。主要结果是 6 小时死亡率。仅接受成分治疗的红细胞的患者被归类为非温热新鲜全血组。非温热新鲜全血患者通过损伤类型、患者隶属关系、止血带使用、院前输血和平均每小时红细胞单位输血率进行频率匹配,创建了临床独特的分层。多水平混合效应逻辑回归调整了匹配、不朽时间偏差和其他协变量。
1105 名研究患者(221 名温热新鲜全血,884 名非温热新鲜全血)被分为 29 个独特的临床分层。温热新鲜全血与非温热新鲜全血组相比,6 小时死亡率的调整优势比为 0.27(95%置信区间 0.13-0.58)。在 422 名具有完整数据的亚组中,调整了 7 个额外协变量后,死亡率的降低幅度更大(优势比=0.15,P=0.024)。温热新鲜全血有剂量依赖性效应,与非温热新鲜全血组相比,接受较高剂量温热新鲜全血(>33%的含红细胞单位)的患者死亡率显著降低。
与非温热新鲜全血相比,温热新鲜全血复苏与战场上伤员 6 小时死亡率显著降低相关,具有剂量依赖性效应。这些发现支持温热新鲜全血在控制出血方面的应用,并支持在军事和平民创伤环境中进行进一步研究。